Polmacoxib (CG100649) is a first-in-class, orally active nonsteroidal anti-inflammatory agent (NSAID) which is a dual inhibitor of COX-2 (IC50 around 0.1 µg/ml) and carbonic anhydrase[1]. Polmacoxib inhibits colorectal adenoma and tumor growth in mouse m
Molecular Weight:
361.39
Purity:
99.70
CAS Number:
[301692-76-2]
Formula:
C18H16FNO4S
Target:
Carbonic Anhydrase,COX
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
